Pregled bibliografske jedinice broj: 479898
Vincristine-resistant human laryngeal carcinoma cells demonstrate increased Rous sarcoma virus promoter activity
Vincristine-resistant human laryngeal carcinoma cells demonstrate increased Rous sarcoma virus promoter activity // Life sciences, 87 (2010), 15/16; 468-474 doi:10.1016/j.lfs.2010.08.012 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 479898 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Vincristine-resistant human laryngeal carcinoma cells demonstrate increased Rous sarcoma virus promoter activity
Autori
Majhen, Dragomira ; Brozović, Anamaria ; Buger, Tvrtko ; Gabrilovac, Jelka ; Osmak, Maja ; Ambriović-Ristov, Andreja
Izvornik
Life sciences (0024-3205) 87
(2010), 15/16;
468-474
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
promoter; adenovirus; vincristine; resistance
Sažetak
Gene therapy is a candidate approach for treating cancer patients whose tumors have developed resistance to some drugs. Our study aims to examine possible alteration in Ad5RSVβgal-mediated transgene expression in a vincristine-resistant cells (VK2) derived from the human laryngeal carcinoma cell line HEp2, and the underlying mechanism(s) thereof. Adenovirus-mediated transgene expression in HEp2 and VK2 cells was measured by β-gal staining. Semiquantitative PCR was used to evaluate attachment of adenovirus to the cell surface and adenovirus internalization into cells. After transfection of cells with plasmid DNA, promoter activity was measured by semiquantitative RT-PCR. We show here that VK2 cells exhibited increased Ad5RSVβgal-mediated transgene expression, despite moderately decreased Ad5RSVβgal attachment and internalization, as compared with HEp2 cells. The increased transgene expression was also observed with a virus (Ad5FbΔ639RSVβgal) that does not use the coxsackie-adenovirus receptor (CAR), suggesting that increased transgene expression is independent of CAR. Upon transfection of VK2 cells with a plasmid expressing a reporter gene under the control of the RSV promoter or a plasmid containing the complete Ad5RSVβgal genome, RSV promoter activity was 33- and 4.7-fold higher, respectively, than in HEp2 cells. The increased Ad5RSVβgal-mediated transgene expression in the VK2 cells is due to the increased RSV promoter activity in VK2 cells. Our results point out that (i) drug-resistance may be accompanied with an alteration in promoter activity ; (ii) the proper choice of promoter could contribute to a decrease in the vector dose required to achieve a therapeutic effect during gene therapy.
Izvorni jezik
Engleski
Znanstvena područja
Biologija
Napomena
Majhen, Dragomira i Brozovic, Anamaria su autorice koje dijele prvo mjesto na radu
POVEZANOST RADA
Projekti:
098-0982464-2520 - Uloga membranskih peptidaza na tumorskim i normalnim stanicama (Gabrilovac, Jelka, MZOS ) ( CroRIS)
098-0982913-2748 - Stanični odgovor na citotoksične spojeve i razvoj otpornosti (Osmak, Maja, MZOS ) ( CroRIS)
098-0982913-2850 - Povećanje transdukcije adenovirusnih vektora i otpornost stanica na citostatike (Ambriović Ristov, Andreja, MZOS ) ( CroRIS)
Ustanove:
Institut "Ruđer Bošković", Zagreb
Profili:
Jelka Gabrilovac
(autor)
Dragomira Majhen
(autor)
Anamaria Brozović
(autor)
Maja Osmak
(autor)
Andreja Ambriović Ristov
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE